Terug
Dagbereik
€ 9,46
€ 10,09
52-Weeksbereik
€ 3,97
€ 18,67
Volume
993.475
50D / 200D Gem.
€ 13,00
/
€ 10,48
Vorige Slotkoers
€ 9,53
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,9 | 0,4 |
| P/B | 1,6 | 2,9 |
| ROE % | -102,4 | 3,7 |
| Net Margin % | -36,2 | 3,8 |
| Rev Growth 5Y % | -2,9 | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Revenue declined -2,85% annually over 5 years
Debt/Equity of 0,12 — conservative balance sheet
Generating 88,30M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,85%
Capital efficient — spends only 0,93% of revenue on capex
Groei
Revenue Growth (5Y)
-2,85%
Revenue (1Y)1,00%
Earnings (1Y)N/A
FCF Growth (3Y)-16,98%
Kwaliteit
Return on Equity
-102,41%
ROIC-3,63%
Net Margin-36,21%
Op. Margin-1,12%
Veiligheid
Debt / Equity
0,12
Current Ratio0,98
Interest Coverage-0,33
Waardering
P/E Ratio
-0,92
P/B Ratio1,62
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,00% | Revenue Growth (3Y) | -2,12% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2,85% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,72B | Net Income (TTM) | -986,20M |
| ROE | -102,41% | ROA | -36,31% |
| Gross Margin | 15,63% | Operating Margin | -1,12% |
| Net Margin | -36,21% | Free Cash Flow (TTM) | 88,30M |
| ROIC | -3,63% | FCF Growth (3Y) | -16,98% |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 0,98 |
| Interest Coverage | -0,33 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -0,92 | P/B Ratio | 1,62 |
| P/S Ratio | 0,33 | PEG Ratio | -0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 911,63M | Enterprise Value | 805,03M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,72B | 2,70B | 2,84B | 2,84B | 3,06B |
| Net Income | -986,20M | -328,50M | -25,20M | 186,20M | 98,00M |
| EPS (Diluted) | -10,81 | -3,67 | -0,04 | 2,11 | 1,11 |
| Gross Profit | 425,80M | 534,20M | 590,60M | 724,40M | 604,40M |
| Operating Income | -30,60M | -161,90M | 32,00M | 187,10M | 114,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,72B | 3,58B | 4,33B | 4,29B | 4,37B |
| Total Liabilities | 2,15B | 2,22B | 2,62B | 945,30M | 1,11B |
| Shareholders' Equity | 563,50M | 1,36B | 1,71B | 3,34B | 3,26B |
| Total Debt | 68,00M | 1,20B | 1,67B | 63,40M | 77,20M |
| Cash & Equivalents | 174,60M | 118,50M | 108,60M | 112,00M | 94,60M |
| Current Assets | 897,20M | 948,20M | 1,25B | 1,25B | 1,12B |
| Current Liabilities | 913,30M | 949,50M | 778,40M | 699,00M | 826,70M |